hsa-mir-1179: Hsa-mir-1179 is a microRNA that has been implicated in various biological processes and diseases [PMC9119753]. It has been shown to competitively bind with MIR133A1HG to regulate the expression of COL4A3, and with downregulated C10orf71-AS1 to regulate the expression of COL4A4, thereby potentially affecting focal adhesion, ECM-receptor interaction, and the PI3K-Akt signaling pathway [PMC9119753]. Hsa-mir-1179 has also been hypothesized to indirectly upregulate OX40L expression by blocking hsa_circ_0000652 [PMC8716807]. Biotin-labeled hsa-mir-1179 probes have been found to enrich hsa_circ_0000652 and OX40L mRNA [PMC8716807]. Abnormally high expression of hsa-mir-1179, along with hsa-mir-4797-3p and hsa-mir-665, has been observed in diabetic retinopathy patients, suggesting their potential as biomarkers for early clinical diagnosis of the disease [PMC9523404]. Hsa-mir-1179 has also been implicated in hepatocellular carcinoma progression and metastasis [PMC7467934]. It is a part of the ceRNA network associated with hsa_circRNA_012448, along with other hub miRNAs [PMC8973950]. In gastric cancer, hsa-mir-1179 is predicted to be associated with KNL1 [PMC6215350]. Finally, it is negatively correlated with ABCA8, ABCA12, ABCB6, ABCB8, and ABCC10 gene expressions in a study on drug resistance mechanisms [PMC9273952].